Exercise Helps Reduce Side Effects From Cancer Treatment
By Lori Solomon HealthDay Reporter
.jpg?width=1200)
THURSDAY, May 1, 2025 -- Exercise mitigates adverse outcomes associated with cancer and its treatments, according to a review published online April 29 in the British Journal of Sports Medicine.
Xue-Li Bai, from the Fourth Affiliated Hospital of China Medical University in Shenyang, and colleagues conducted a systematic literature review to examine the comprehensive health impacts of exercise on people with cancer.
Based on 80 articles, all rated as moderate-to-high quality, the researchers found that 260 of the 485 associations (53.6 percent) were statistically significant and 81 (16.7 percent) were supported by high-certainty evidence according to the Grading of Recommendations Assessment, Development, and Evaluation criteria. There was moderate- to high-certainty evidence that exercise significantly mitigates adverse events associated with cancer and its treatments (e.g., cardiac toxicity, chemotherapy-induced peripheral neuropathy, cognitive impairment, and dyspnea), compared with usual care or no exercise. In people with cancer, exercise also modulated body composition and biomarkers (e.g., insulin, insulin-like growth factor-1, insulin-like growth factor-binding protein-1, and C-reactive protein) and enhances sleep quality, psychological well-being, physiological functioning, social interaction, and overall quality of life.
"Exercise reduces adverse events and enhances well-being through a range of health outcomes in people with cancer," the authors write. "This study reinforces the efficacy of incorporating exercise into cancer treatment protocols."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine
MONDAY, June 23, 2025 -- The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately...
Gluten-Stimulated Interleukin-2 Secretion Useful for Diagnosing Celiac Disease
MONDAY, June 23, 2025 -- Gluten-stimulated interleukin-2 (IL-2) secretion is useful for diagnosis of celiac disease (CeD), according to a study published online June 9 in...
Minor Complications Up for Black Patients After Weight-Loss Surgery
MONDAY, June 23, 2025 -- Black patients have a higher incidence of minor complications after metabolic and bariatric surgery, according to a study presented at the annual meeting...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.